GlassScriptPhysician profile
Katie Brenner
NPI 1942641691
$1,454.74
in general payments reported to CMS, 2019-2025
23 companies · $408 in 2025
The $408 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $374 · 2020: $20.64 · 2021: $94.41 · 2022: $142 · 2023: $307 · 2024: $108 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $823.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $348.89 | 2021-2025 | Vraylar, Ubrelvy |
| Novo Nordisk INC | $217.29 | 2019-2025 | Ozempic, Rybelsus |
| Abbott Laboratories | $214.62 | 2019-2025 | Freestyle Libre 2 |
| Amgen INC. | $92.37 | 2019-2025 | Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.42 | 2019-2025 | Jardiance, Ofev |
| Astellas Pharma US INC | $88.79 | 2019-2023 | Veozah |
| Lilly USA, LLC | $71.31 | 2019-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $58.91 | 2019-2021 | |
| Dexcom, INC. | $30.89 | 2022-2023 | Dexcom G6 Transmitter |
| Inspire Medical Systems, INC. | $28.76 | 2025 | Inspire |
| Pfizer INC. | $26.21 | 2019 | |
| Dynavax Technologies Corporation | $24.33 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $18.47 | 2021 | |
| Phathom Pharmaceuticals, INC. | $16.89 | 2025 | Voquezna |
| Exact Sciences Corporation | $15.96 | 2023 | Cologuard Collection Kit |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $15.72 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.55 | 2019 | |
| Radius Health, INC. | $15.53 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.29 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.00 | 2019 | |
| Strongbridge US INC. | $12.49 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.17 | 2021 | |
| Bioventus LLC | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Brenner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.